Celularity Inc.CELUNASDAQ

Revenue (LTM)

$54M

+138.1% YoY

Net Income (LTM)

$-58M

+70.5% YoY

Free Cash Flow

$-7M

Revenue CAGR (5Y)

+20.7%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	14	21↑49.4%	18↓15.7%	23↑26.7%	54↑138.1%
Gross Profit	9	12↑25.0%	-2↓114.5%	7↑499.7%	39↑480.8%
Operating Income	-152	-109↑28.2%	-26↑76.5%	-192↓651.1%	-38↑80.1%
Net Income	-208	-100↑51.9%	14↑114.2%	-196↓1483.1%	-58↑70.5%
EBITDA	-202	-88↑56.5%	-139↓57.6%	-184↓32.5%	-44↑76.2%
EPS Diluted	-113.06	-14.93↑86.8%	0.95↑106.3%	-11.02↓1263.4%	-2.64↑76.0%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	54	37↓31.4%	14↓62.5%	0↓98.4%	1↑225.1%
Total Current Assets	72	59↓18.1%	34↓43.3%	20↓40.9%	21↑3.9%
Total Assets	431	414↓3.9%	401↓3.2%	144↓64.1%	133↓7.8%
Total Current Liabilities	27	26↓1.7%	62↑136.8%	67↑8.4%	54↓20.2%
Total Liabilities	412	315↓23.7%	202↓35.8%	103↓49.1%	124↑20.3%
Total Equity	19	99↑431.3%	199↑100.1%	41↓79.4%	9↓78.4%
Total Debt	31	31↑1.6%	66↑110.7%	65↓0.3%	69↑5.2%
Net Debt	-24	-6↑74.2%	52↑945.7%	65↑26.3%	68↑4.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-63	-110↓74.2%	-138↓25.2%	-39↑71.9%	-6↑83.5%
Capital Expenditure	-28	-6↑77.7%	-5↑15.6%	-4↑22.7%	-0↑96.0%
Free Cash Flow	-91	-116↓27.8%	-143↓23.1%	-43↑70.1%	-7↑84.6%
Stock-Based Comp	4	40↑815.4%	16↓60.4%	15↓5.3%	12↓23.0%
Net Change in Cash	26	-17↓167.0%	-23↓33.5%	-19↑19.9%	1↑104.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance